|
市場調査レポート
商品コード
1789444
組換えタンパク質市場：製品タイプ別、発現システム別、用途別、エンドユーザー別、地域別Recombinant Protein Market, by Product Type, by Expression System, by Application, by End User, by Region |
||||||
カスタマイズ可能
|
|||||||
価格
| 組換えタンパク質市場：製品タイプ別、発現システム別、用途別、エンドユーザー別、地域別 |
|
出版日: 2025年07月28日
発行: Coherent Market Insights
ページ情報: 英文 270 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
組換えタンパク質市場は、2025年には38億9,250万米ドルと推定され、2032年には83億3,970万米ドルに達すると予測され、2025～2032年のCAGRは11.5%で成長する見込みです。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024年 | 2025年の市場規模 | 38億9,250万米ドル |
| 実績データ | 2020～2024年 | 予測期間 | 2025～2032年 |
| 予測期間：2025～2032年 | 11.50% | 2032年の金額予測 | 83億3,970万米ドル |
組換えタンパク質は、遺伝子発現とメッセンジャーRNAの翻訳をサポートする発現ベクタにクローン化された組換えDNAによってコードされるタンパク質です。組換えDNA技術による遺伝子の改変は、変異タンパク質の発現をもたらすことがあります。組換えタンパク質は、タンパク質の生産を増加させ、遺伝子配列を変化させ、有用な商品を生産するために、様々な方法で生産される天然タンパク質の操作された形態です。
多くの組換えタンパク質は、真核生物、酵母、哺乳類、昆虫の細胞培養系でのみ利用可能な、グリコシル化などの翻訳後修飾を必要とし、それを記載しています。一過性のタンパク質生産にはHEK293由来の細胞株が用いられます。現在、ほとんどの組換え治療用タンパク質は、自然界にあるものと同様の高品質のタンパク質を産生する能力があるため、哺乳動物細胞で産生されています。加えて、多くの承認された組換え治療用タンパク質は、大腸菌で生産されています。その理由は、遺伝学的によく特徴付けられ、増殖が速く、高収率で生産できるからです。
市場力学
同社は、世界市場で強固な骨格を築くため、買収や提携といった戦略の採用に注力しています。例えば、2021年12月、Thermo Fisher Scientificは組換えタンパク質の開発・製造会社であるペプロテック社を買収しました。この買収により、Thermo Fisher Scientificは組換えタンパク質のポートフォリオを強化することになります。
規制当局による組換えホルモンの生物製剤認可申請の承認が増加していることは、予測期間中の市場成長を促進すると予想されます。例えば、2022年1月、多国籍製薬とバイオテクノロジー企業であるPfizer Inc.とバイオテクノロジー企業であるOPKO Health, Inc.は、米国食品医薬品局（FDA）がソマトロゴンの生物製剤ライセンス申請（BLA）に対する審査完了報告書（CRL）を発行したと発表しました。ソマトロゴンは、小児における成長ホルモン分泌不全症（GHD）の治療を適応とする、週1回投与の長時間作用型遺伝子組換えヒト成長ホルモン製剤です。
本調査の主要特徴
- 本レポートでは、世界の遺伝子組換えタンパク質市場を詳細に分析し、2024年を基準年とした予測期間2025～2032年の市場規模（100万米ドル）と複合年間成長率（CAGR%）を提供しています。
- 異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
- また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
- 主要な企業プロファイルとして、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などを掲載しています。主要な企業として、Merck KGaA、OriGene Technologies, Inc、Feldan Therapeutics、ACROBiosystems、Abcam plc.、Randox Laboratories Ltd.、SOL GROUP、Proteintech Group, Inc.、Planet BIoTechnology, Inc.、INFINITE ENZYMES, INC.、ORF Genetics、GenScript、BTL BIoTechno Labs Pvt Ltd.、Prospec-Tany Technogene Ltd.、BPS Bioscience, Inc.、Sino Biological、Cape Bio Pharms、Abnova Corporation、GeNext Genomics。
- このレポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
- 組換えタンパク質の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業のさまざまな利害関係者に対応しています。
- 利害関係者は、世界のリコンビナントタンパク市場分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 一貫型機会マップ（COM）
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場の魅力分析
- 市場機会
- 製品の発売
- 合併、買収、提携
- 規制ガイドラインとコンプライアンス
- 政府の介入
- PEST分析
- 技術
- ブランド属性マッピング
- 投資
- 価格分析（2021年）
第4章 世界の組換えタンパク質市場、製品タイプ別、2020～2032年
- イントロダクション
- 抗体
- 抗原
- 酵素
- ホルモン
- その他
第5章 世界の組換えタンパク質市場、発現システム別、2020～2032年
- イントロダクション
- 微生物
- 植物
- 動物
第6章 世界の組換えタンパク質市場、用途別、2020～2032年
- イントロダクション
- 医薬品の発見と開発
- 研究申請
- 治療目的の使用
- 診断
- その他
第7章 世界の組換えタンパク質市場、エンドユーザー別、2020～2032年
- イントロダクション
- バイオテクノロジーと製薬会社
- 学術研究機関
- 契約研究機関
- その他
第8章 世界の組換えタンパク質市場、地域別、2020～2032年
- イントロダクション
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ
- 欧州
- 英国
- ドイツ
- イタリア
- フランス
- スペイン
- ロシア
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- ASEAN諸国
- オーストラリア
- 韓国
- その他のアジア太平洋
- 中東
- GCC諸国
- イスラエル
- その他の中東
- アフリカ
- 北アフリカ
- 中央アフリカ
- 南アフリカ
第9章 競合情勢
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet BIoTechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL BIoTechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
第10章 セクション
- 調査手法
- 出版社について
目次
Product Code: CMI1516
Recombinant Protein Market is estimated to be valued at USD 3,892.5 Mn in 2025 and is expected to reach USD 8,339.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,892.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.50% | 2032 Value Projection: | USD 8,339.7 Mn |
A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.
Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.
Market Dynamics
The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.
The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.
Key features of the study
- This report provides in-depth analysis of the global recombinant protein market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.
Market Segmentation
- Global Recombinant Protein Market, By Product Type
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
- Global Recombinant Protein Market, By Expression System
- Microbes
- Plant
- Animal
- Global Recombinant Protein Market By Application
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
- Global Recombinant Protein Market By End User
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institute
- Contract Research Organization
- Others
- Global Recombinant Protein Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet Biotechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL Biotechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Expression System
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Government Intervention
- PEST Analysis
- Technology Landscape
- Brand Attribute Mapping
- Investments
- Pricing Analysis (2021)
4. Global Recombinant Protein Market, By Product Type, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Recombinant Protein Market, By Expression System, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microbes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Recombinant Protein Market, By Application, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Therapeutic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Recombinant Protein Market, By End User, 2020 - 2032, (USD Mn
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Recombinant Protein Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Feldan Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Proteintech Group, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Planet Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- INFINITE ENZYMES, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORF Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BTL Biotechno Labs Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Prospec-Tany Technogene Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BPS Bioscience, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cape Bio Pharms
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GeNext Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
